Feiba

Product Specs Description
Manufacturer Name Takeda
Indications

For use in hemophilia A and B patients with inhibitors for:

  • Control and prevention of bleeding episodes
  • Perioperative management
  • Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.
Contraindications Patients who havea history of anaphylactic or severe hypersensitivity reactions to FEIBA or any of its components, including factors of the kinin generating system, disseminated intravascular coagulation (DIC) or acute thrombosis or embolism (including myocardial infarction).
Viral Safety Process Vapor heat treatment and 35 nm nanofiltration
Product Half-Life N/A; Dosing intervals: 6-12 hours by type of hemorrhage
Manufacturing Method Plasma Derived
Storage Requirements/Shelf Life
  • Store at 36°F to 77°F (2°C to 25°C)
  • Store in the original package to protect from light.
  • Do not freeze.
  • Prior to preparation and reconstitution, allow the vials to reach room temperature, if refrigerated.
Nominal Vial Size & Diluent Volume 500 or 1000 IU/20 mL
2500 IU/50 mL


MANUFACTURER NAME LISTING


FACTOR TYPE LISTING